While this study reveals a complex toxic mechanism of TH588 and TH1579 killing c-Myc overexpressing cells, which also involves MTH1-independent effects of the compounds, the cancer selective killing of these compounds is confirmed and supports further development of TH1579 in the clinic in treatment of cancer. The gene discussed is MYC; the disease is cancer.